Antidepressants in elderly: Metaregression of double-blind, randomized clinical trials

Journal of Affective Disorders

Volumn 147, Issue 1-3, 2013, Pages 1-8

  Calati, Raffaella ^a   Salvina Signorelli, Maria ^b   Balestri, Martina ^c   Marsano, Agnese ^c   De Ronchi, Diana ^c   Aguglia, Eugenio ^b   Serretti, Alessandro ^c  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antidepressant; Clinic profile; Depression; Effectiveness; Elderly; Older

Indexed keywords

ANTIDEPRESSANT AGENT;

DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; GERIATRIC DISORDER; HAMILTON SCALE; HUMAN; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SOCIAL STATUS; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SEROTONIN UPTAKE INHIBITORS;

EID: 84875364119     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.11.053     Document Type: Review

References (87)

1. P. Allard, L. Gram, K. Timdahl, K. Behnke, M. Hanson, and J. Sogaard Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram International Journal of Geriatric Psychiatry 19 2004 1123 1130
2. A.C. Altamura, M. Percudani, G. Guercetti, and G. Invernizzi Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline International Clinical Psychopharmacology 4 Suppl 1 1989 103 106
3. C. Andreescu, B.H. Mulsant, P.R. Houck, E.M. Whyte, S. Mazumdar, A.Y. Dombrovski, B.G. Pollock, and C.F. Reynolds 3rd Empirically derived decision trees for the treatment of late-life depression American Journal of Psychiatry 165 2008 855 862
4. L.C. Barry, J.J. Abou, A.A. Simen, and T.M. Gill Under-treatment of depression in older persons Journal of Affective Disorders 136 2012 789 796
5. K.L. Bigos, B.G. Pollock, B.A. Stankevich, and R.R. Bies Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review Gender Medicine 6 2009 522 543
6. W. Bondareff, M. Alpert, A.J. Friedhoff, E.M. Richter, C.M. Clary, and E. Batzar Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life American Journal of Psychiatry 157 2000 729 736
7. A. Bose, D. Li, and C. Gandhi Escitalopram in the acute treatment of depressed patients aged 60 years or older American Journal of Geriatric Psychiatry 16 2008 14 20
8. R.D. Boyce, J.T. Hanlon, J.F. Karp, J. Kloke, A. Saleh, and S.M. Handler A Review of the effectiveness of antidepressant medications for depressed nursing home residents Journal of the American Medical Directors Association 2011
9. A.B. Burrows, C. Salzman, A. Satlin, K. Noble, B.G. Pollock, and T. Gersh A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression Depress Anxiety 15 2002 102 110
10. G.B. Cassano, F. Puca, P.L. Scapicchio, and M. Trabucchi Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients Journal of Clinical Psychiatry 63 2002 396 402
11. G.E. Caughey, E.E. Roughead, S. Shakib, R.A. McDermott, A.I. Vitry, and A.L. Gilbert Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants Age Ageing 39 2010 488 494
12. K.L. Chou, and I. Chi Prevalence of depression among elderly Chinese with diabetes International Journal of Geriatric Psychiatry 20 2005 570 575
13. C. Cidis Meltzer, W.C. Drevets, J.C. Price, C.A. Mathis, B. Lopresti, P.J. Greer, V.L. Villemagne, D. Holt, N.S. Mason, P.R. Houck, C.F. Reynolds 3rd, and S.T. DeKosky Gender-specific aging effects on the serotonin 1 A receptor Brain Research 895 2001 9 17
14. E. Corruble, P. Gorwood, and B. Falissard Association between age of onset and symptom profiles of late-life depression Acta Psychiatrica Scandinavica 118 2008 389 394
15. D.P. Devanand, M.S. Nobler, J. Cheng, N. Turret, G.H. Pelton, S.P. Roose, and H.A. Sackeim Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder American Journal of Geriatric Psychiatry 13 2005 59 68
16. M. Evans, M. Hammond, K. Wilson, M. Lye, and J. Copeland Placebo-controlled treatment trial of depression in elderly physically ill patients International Journal of Geriatric Psychiatry 12 1997 817 824
17. S.I. Finkel, E.M. Richter, and C.M. Clary Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older International Psychogeriatrics 11 1999 85 99
18. O.V. Forlenza, A. Stoppe Junior, E.S. Hirata, and R.C. Ferreira Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients Sao Paulo Medical Journal 118 2000 99 104
19. J.C. Fournier, R.J. DeRubeis, S.D. Hollon, S. Dimidjian, J.D. Amsterdam, R.C. Shelton, and J. Fawcett Antidepressant drug effects and depression severity: a patient-level meta-analysis Journal of the American Medical Association 303 2010 47 53
20. E.J. Frackiewicz, J.J. Sramek, and N.R. Cutler Gender differences in depression and antidepressant pharmacokinetics and adverse events The Annals of Pharmacotherapy 34 2000 80 88
21. E.S. Friedman, S.R. Wisniewski, W. Gilmer, A.A. Nierenberg, A.J. Rush, M. Fava, S. Zisook, G.K. Balasubramani, and M.H. Trivedi Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR()D trial. Depression and Anxiety 26 2009 612 621
22. C. Gasto, V. Navarro, T. Marcos, M.J. Portella, M. Torra, and M. Rodamilans Single-blind comparison of venlafaxine and nortriptyline in elderly major depression Journal of Clinical Psychopharmacology 23 2003 21 26
23. C. Geretsegger, F. Bohmer, and M. Ludwig Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects International Clinical Psychopharmacology. 9 1994 25 29
24. R. Gerner, W. Estabrook, J. Steuer, L. Waltuch, P. Kakkar, and L. Jarvik A placebo-controlled double-blind study of imipramine and trazodone in geriatric depression Proceedings of the Annual Meeting of the American Psychopathological Association 69 1980 167 182
25. W.S. Gilmer, J.K. Gollan, S.R. Wisniewski, R.H. Howland, M.H. Trivedi, S. Miyahara, J. Fleck, M.E. Thase, J.E. Alpert, A.A. Nierenberg, D. Warden, M. Fava, and A.J. Rush Does the duration of index episode affect the treatment outcome of major depressive disorder? A STARD report The Journal of Clinical Psychiatry 69 2008 1246 1256
26. A. Graziottin, and A. Serafini Depression and the menopause: why antidepressants are not enough? Menopause International 15 2009 76 81
27. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
28. J.M. Hegeman, R.M. Kok, R.C. van der Mast, and E.J. Giltay Phenomenology of depression in older compared with younger adults: meta-analysis The British Journal of Psychiatry 200 2012 275 281
29. V. Henkel, F. Seemuller, M. Obermeier, M. Adli, M. Bauer, K. Kronmuller, F. Holsboer, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, A. Mayr, M. Riedel, and H.J. Moller Relationship between baseline severity of depression and antidepressant treatment outcome Pharmacopsychiatry 44 2011 27 32
30. R.H. Howland, M.G. Wilson, S.G. Kornstein, A.H. Clayton, M.H. Trivedi, M.M. Wohlreich, and M. Fava Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression Annals of Clinical Psychiatry 20 2008 209 218
31. D.R. Hutchinson, S. Tong, C.A. Moon, M. Vince, and A. Clarke Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline International Clinical Psychopharmacology 6 Suppl 4 1992 43 51
32. C.F. Hybels, and D.G. Blazer Epidemiology of late-life mental disorders Clinics in Geriatric Medicine 19 2003 663 696 v
33. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, and H.J. McQuay Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 17 1996 1 12
34. M.W. Jann, and L.J. Cohen The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression Drug Metabolism and Drug Interactions 16 2000 39 67
35. S. Kasper, H. de Swart, and H. Friis Andersen Escitalopram in the treatment of depressed elderly patients American Journal of Geriatric Psychiatry 13 2005 884 891
36. A. Khan, R.M. Leventhal, S.R. Khan, and W.A. Brown Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database Journal of Clinical Psychopharmacology 22 2002 40 45
37. R.M. Kok, T.J. Heeren, and W.A. Nolen Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants American Journal of Geriatric Psychiatry 19 2011 249 255
38. R.M. Kok, W.A. Nolen, and T.J. Heeren Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial International Journal of Geriatric Psychiatry 22 2007 1247 1254
39. R.M. Kok, W.A. Nolen, and T.J. Heeren Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants Journal of Affective Disorders 2012
40. S.G. Kornstein, and G. McEnany Enhancing pharmacologic effects in the treatment of depression in women The Journal of Clinical Psychiatry 61 Suppl 11 2000 18 27
41. S.G. Kornstein, A.F. Schatzberg, M.E. Thase, K.A. Yonkers, J.P. McCullough, G.I. Keitner, A.J. Gelenberg, C.E. Ryan, A.L. Hess, W. Harrison, S.M. Davis, and M.B. Keller Gender differences in chronic major and double depression Journal of Affective Disorders 60 2000 1 11
42. I.M. Lesser, H.F. Myers, K.M. Lin, C. Bingham Mira, N.T. Joseph, N.T. Olmos, J. Schettino, and R.E. Poland Ethnic differences in antidepressant response: a prospective multi-site clinical trial Depression and Anxiety 27 2010 56 62
43. J.M. Lyness, Q. Yu, W. Tang, X. Tu, and Y. Conwell Risks for depression onset in primary care elderly patients: potential targets for preventive interventions American Journal of Psychiatry 166 2009 1375 1383
44. S.N. Mahapatra, and D. Hackett A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression International Journal of Clinical Practice 51 1997 209 213
45. N. Mittmann, N. Herrmann, T.R. Einarson, U.E. Busto, K.L. Lanctot, B.A. Liu, K.I. Shulman, I.L. Silver, C.A. Narango, and N.H. Shear The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis Journal of Affective Disorders 46 1997 191 217
46. H.J. Moller, J. Schnitker, and W. Flurenbrock Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany Pharmacopsychiatry 43 2010 210 215
47. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change The British Journal of Psychiatry 134 1979 382 389
48. P. Mottram, K. Wilson, and J. Strobl Antidepressants for depressed elderly Cochrane Database of Systematic Reviews 2006 CD003491
49. Y. Mukai, and R.R. Tampi Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants Clinical Therapeutics 31 2009 945 961
50. B.H. Mulsant, R.A. Sweet, J. Rosen, B.G. Pollock, G.S. Zubenko, T. Flynn, A.E. Begley, S. Mazumdar, and C.F. Reynolds 3rd A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life Journal of Clinical Psychiatry 62 2001 597 604
51. V. Navarro, C. Gasto, X. Torres, T. Marcos, and L. Pintor Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study Acta Psychiatrica Scandinavica 103 2001 435 440
52. J.C. Nelson, K. Delucchi, and L.S. Schneider Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence American Journal of Geriatric Psychiatry 16 2008 558 567
53. P.A. Newhouse, K.R. Krishnan, P.M. Doraiswamy, E.M. Richter, E.D. Batzar, and C.M. Clary A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients Journal of Clinical Psychiatry 61 2000 559 568
54. A.L. Nyth, C.G. Gottfries, K. Lyby, L. Smedegaard-Andersen, J. Gylding-Sabroe, M. Kristensen, H.E. Refsum, E. Ofsti, S. Eriksson, and S. Syversen A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia Acta Psychiatrica Scandinavica 86 1992 138 145
55. G.I. Papakostas, and M. Fava Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder Dialogues in Clinical Neuroscience 10 2008 439 451
56. M. Park, and J. Unutzer Geriatric depression in primary care Psychiatric Clinics of North America 34 2011 469 487 ix-x
57. M.A. Pimontel, M.E. Culang-Reinlieb, S.S. Morimoto, and J.R. Sneed Executive dysfunction and treatment response in late-life depression International Journal of Geriatric Psychiatry 2011
58. M. Pinquart, P.R. Duberstein, and J.M. Lyness Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy American Journal of Psychiatry 163 2006 1493 1501
59. M.H. Rapaport, R.B. Lydiard, C.D. Pitts, D. Schaefer, E.I. Bartolic, M. Iyengar, M. Carfagno, and A. Lipschitz Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial Journal of Clinical Psychiatry 70 2009 46 57
60. M.H. Rapaport, L.S. Schneider, D.L. Dunner, J.T. Davies, and C.D. Pitts Efficacy of controlled-release paroxetine in the treatment of late-life depression Journal of Clinical Psychiatry 64 2003 1065 1074
61. J. Raskin, C.G. Wiltse, A. Siegal, J. Sheikh, J. Xu, J.J. Dinkel, B.T. Rotz, and R.C. Mohs Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial American Journal of Psychiatry 164 2007 900 909
62. T.M. Richardson, B. Friedman, C. Podgorski, K. Knox, S. Fisher, H. He, and Y. Conwell Depression and its correlates among older adults accessing aging services American Journal of Geriatric Psychiatry 20 2012 346 354
63. S.P. Roose, M. Miyazaki, D. Devanand, S. Seidman, L. Fitzsimmons, N. Turret, and H. Sackeim An open trial of venlafaxine for the treatment of late-life atypical depression International Journal of Geriatric Psychiatry 19 2004 989 994
64. C. Rosenberg, L. Lauritzen, J. Brix, J.B. Jorgensen, P. Kofod, and L.B. Bayer Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice Psychopharmacology Bulletin 40 2007 63 73
65. A. Schatzberg, and S. Roose A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression American Journal of Geriatric Psychiatry 14 2006 361 370
66. L.S. Schneider, J.C. Nelson, C.M. Clary, P. Newhouse, K.R. Krishnan, T. Shiovitz, and K. Weihs An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression American Journal of Psychiatry 160 2003 1277 1285
67. W. Schone, and M. Ludwig A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression Journal of Clinical Psychopharmacology 13 1993 34S 39S
68. A. Serretti, R. Calati, A. Goracci, M. Di Simplicio, P. Castrogiovanni, and D. De Ronchi Antidepressants in healthy subjects: what are the psychotropic/psychological effects? European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 20 2010 433 453
69. A. Serretti, R. Calati, O. Oasi, D. De Ronchi, and C. Colombo Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases Annals of General Psychiatry 6 2007 5
70. A. Serretti, A. Chiesa, R. Calati, G. Perna, L. Bellodi, and D. De Ronchi Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders International Clinical Psychopharmacology 24 2009 1 18
71. A. Serretti, S. Gibiino, and A. Drago Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials Journal of Affective Disorders 132 2011 14 25
72. J.I. Sheikh, E.L. Cassidy, P.M. Doraiswamy, R.M. Salomon, M. Hornig, P.J. Holland, F.S. Mandel, C.M. Clary, and T. Burt Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness Journal of the American Geriatrics Society 52 2004 86 92
73. Y.I. Sheline, B.M. Disabato, J. Hranilovich, C. Morris, G. D'Angelo, C. Pieper, T. Toffanin, W.D. Taylor, J.R. Macfall, C. Wilkins, D.M. Barch, K.A. Welsh-Bohmer, D.C. Steffens, R.R. Krishnan, and P.M. Doraiswamy Treatment Course With Antidepressant Therapy in Late-Life Depression American Journal of Psychiatry 2012
74. J.R. Sneed, B.R. Rutherford, D. Rindskopf, D.T. Lane, H.A. Sackeim, and S.P. Roose Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 16 2008 65 73
75. D.C. Steffens, I. Skoog, M.C. Norton, A.D. Hart, J.T. Tschanz, B.L. Plassman, B.W. Wyse, K.A. Welsh-Bohmer, and J.C. Breitner Prevalence of depression and its treatment in an elderly population: the Cache County study Archives of General Psychiatry 57 2000 601 607
76. R.S. Tan, R.J. Barlow, C. Abel, S. Reddy, A.J. Palmer, A.E. Fletcher, C.G. Nicholl, B.M. Pitt, and C.J. Bulpitt The effect of low dose lofepramine in depressed elderly patients in general medical wards British Journal of Clinical Pharmacology 37 1994 321 324
77. W.D. Taylor, and P.M. Doraiswamy A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future Neuropsychopharmacology 29 2004 2285 2299
78. E. Tedeschini, Y. Levkovitz, N. Iovieno, V.E. Ameral, J.C. Nelson, and G.I. Papakostas Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials The Journal of Clinical Psychiatry 72 2011 1660 1668
79. G.D. Tollefson, J.C. Bosomworth, J.H. Heiligenstein, J.H. Potvin, and S. Holman A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group International Psychogeriatry 7 1995 89 104
80. L. Trick, N. Stanley, U. Rigney, and I. Hindmarch A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice Journal of Psychopharmacology 18 2004 205 214
81. V.M. Wilkins, D. Kiosses, and L.D. Ravdin Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions Journal of Clinical Interventions in Aging 5 2010 323 331
82. J.W. Williams Jr;, J. Barrett, T. Oxman, E. Frank, W. Katon, M. Sullivan, J. Cornell, and A. Sengupta Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults Journal of the American Medical Association 284 2000 1519 1526
83. K. Wilson, P. Mottram, A. Sivanranthan, and A. Nightingale Antidepressant versus placebo for depressed elderly Cochrane Database of Systematic Reviews 2001 CD000561
84. K.C. Wilson, J.R. Copeland, S. Taylor, J. Donoghue, and C.F. McCracken Natural history of pharmacotherapy of older depressed community residents. The MRC-ALPHA Study The British Journal of Psychiatry 175 1999 439 443
85. S.J. Yang, S.Y. Kim, R. Stewart, J.M. Kim, I.S. Shin, S.W. Jung, M.S. Lee, S.H. Jeong, and T.Y. Jun Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: the CRESCEND study Psychiatry Research 189 2011 82 90
86. K.A. Yonkers, J.C. Kando, J.O. Cole, and S. Blumenthal Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication American Journal of Psychiatry 149 1992 587 595
87. E.A. Young, S.G. Kornstein, S.M. Marcus, A.T. Harvey, D. Warden, S.R. Wisniewski, G.K. Balasubramani, M. Fava, M.H. Trivedi, and A. John Rush Sex differences in response to citalopram: a STARD report Journal of Psychiatric Research 43 2009 503 511